Thursday, November 17, 2011

Drugs for unmet needs may soon get faster FDA approval

A new FDA proposal with drug companies might help more people with meningioma and cancer get Mifeprex like I do in a FDA investigational clinical trial.

This proposal might prevent deaths like the tragic story of the real Norma Rae, Crystal Lee Sutton, a union activist who died after a two year struggle with meningioma. There is still no standard chemo for meningioma so insurance companies do not have to pay for any drug therapy for this disease. They delayed paying for any other type of brain cancer therapy for two months. She had already had brain surgery two years in a row which probably used up some type of annual insurance cap on her treatment costs.